Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Champagne could be good for the heart—and other lessons from a new risk analysis
Researchers explored the potential impact of more than 100 risk factors on a person's risk of sudden cardiac arrest. Some of their findings were what you may expect, but others were much more surprising.
Bayer's finerenone reduces risk of AFib, atrial flutter in all CKM syndrome patients
New data published in JACC represents another big win for Bayer's finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD and heart failure, but its potential across the full CKM spectrum remained a bit of a mystery.
Society of Thoracic Surgeons shares new risk calculator for complex aortic procedures
The new resource was built to help care teams plan for ascending aorta and aortic root surgeries.
PFA takes center stage at Heart Rhythm 2025 as medtech companies share new data
Pulsed field ablation was one of the biggest topics at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society. Medtronic, Johnson & Johnson MedTech, Boston Scientific, Abbott, Kardium and Field Medical all shared new data at the conference highlighting the safety and effectiveness of their advanced PFA technologies.
Medtronic receives FDA approval for smallest defibrillation lead of its kind
Medtronic emphasized that this device should be especially valuable when treating younger patients or those with a small anatomy.

Depression treatments can change the brain’s infrastructure in just 6 weeks

The adult brain may be more malleable than scientists previously thought, according to new research presented at the 35th European College of Neuropsychopharmacology.

Apixaban outperforms rivaroxaban when treating patients with AFib and valvular heart disease

Researchers explored data from nearly 20,000 patients, sharing their findings in Annals of Internal Medicine.

More than half of long COVID patients have abnormalities on chest imaging

Nodular patterns were the most commonly visualized abnormality, although several others were observed.

Deepak Bhatt, MD, MPH, executive director of the interventional cardiovascular programs at Brigham and Women’s Hospital, and professor of medicine at Harvard Medical School, explained the new generation of cholesterol lowering agents and their roles in various types of patients.

VIDEO: Deepak Bhatt discusses the role of new cholesterol-lowering agents

Deepak Bhatt, MD, a professor of medicine at Harvard Medical School, details the new generation of cholesterol-lowering agents and their roles in patient care.

Psychiatry, neuroradiology researchers find imaging markers of inheritable depression

Children are at heightened risk of major clinical depression when at least one parent has a history of the disorder. New research shows depression markers appearing on structural and functional brain MRI ahead of symptoms in these “familial risk” offspring from infancy through early adulthood.

transcarotid TAVR TAVI transcatheter aortic valve replacement

Transcarotid TAVR a safe alternative when femoral access is not an option

The conventional transfemoral approach is not always possible during TAVR procedures, leaving care teams with an important decision to make.

The Medtronic SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing, providing users with another option when treating patients for bradycardia. According to Medtronic, this marks the first time the FDA has approved a device for this indication.

Medtronic cardiac lead the first to receive FDA approval for conduction system pacing

The company’s SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing.

Brain imaging scans unlock mysteries about depression and resilience

The new findings may contain important implications for neuromodulation therapies to treat depression symptoms.

Clinical

Champagne could be good for the heart—and other lessons from a new risk analysis

Bayer's finerenone reduces risk of AFib, atrial flutter in all CKM syndrome patients

Society of Thoracic Surgeons shares new risk calculator for complex aortic procedures

PFA takes center stage at Heart Rhythm 2025 as medtech companies share new data

Medtronic receives FDA approval for smallest defibrillation lead of its kind